Targeting Epidermal Growth Factor Receptor by MiRNA-145 Inhibits Cell Growth and Sensitizes NSCLC Cells to Erlotinib 25 August 2020 | 10:20 Code : 11365 New Features Send To Others Your Name Your Email Recipient Email Send Cancel visits:19025 http://http://journal.waocp.org/article_88725.html
